PACS Group, Inc.

PACS Healthcare Medical Care Facilities

PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.

Revenue
+11.5%
EPS
+16.4%
Free cash flow
−4.31%
Total debt
+7.48%

Quarter to September 2026, against a year earlier

50.09 0.17 −0.34%
Market cap
$8.0B
P/E
28.6×
Fwd P/E
21.8×
Dividend yield
—
F-score
7/9
Altman Z
2.00
Beneish M
−2.74
Dividend safety
n/a

PACS Group, Inc. (PACS) Return on equity

Alert me on Return on equity

PACS Group, Inc.'s return on equity over the twelve months to 30 September 2026 was 26.5%, up 3.5 percentage points from fiscal 2025 (23.0%). Over the past ten years it has ranged from 0.00% (fiscal 2022) to 132.5% (fiscal 2023); the current reading is higher than 80% of that period. That is above the Medical Care Facilities industry median of 5.03% and above the Healthcare sector median of −26.3%.

Return on equity, annual

Embed this chart

Annual newest first

Period Return on equity Change (points)
FY2025 23.0% 9.32
FY2024 13.6% (118.86)
FY2023 132.5% 132.50
FY2022 0.00% 0.00
FY2021 0.00% —

Against its own ten years

Low 0.00% High 132.5%
Ten-year median 13.6%
Current reading's percentile 80

Return on equity against peers

What Return on equity is

ROE shows how much profit a company earns for its shareholders on the equity they have in the business.

Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)

The full definition of Return on equity →

More on PACS